Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2020
Where the money goes
Where each dollar of revenue went, fiscal 2020
- Other costs100¢$14.2K
Out of $14.2K in revenue.42 The company lost money this year.
Financial statements
No quarterly figures reported.
No quarterly figures reported.
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare Kyto Technology & Life Science, Inc. with another company
What it owns
What Kyto Technology & Life Science, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led Kyto Technology & Life Science, Inc., and when. Pick a name to see everywhere that person has worked.
President
- PresidentGeorges Benarroch Jan 11, 2010 to Oct 9, 20147
Board members and other officers (2)
- OfficerGeorges Benarroch Feb 21, 2018 to Feb 21, 20188
- Board memberGeorges Benarroch Jan 9, 2006 to Apr 14, 20219
Former names
Timeline
Filings
22 filings to the SEC since October 2021: 4 quarterly reports, 4 major events, 14 other. The latest 20:
- May 12, 202215-12G EDGAR
- May 9, 2022S-8 POS EDGAR
- May 9, 2022SC TO-I/A EDGAR
- May 9, 20228-K EDGAR
- May 5, 2022SC TO-I/A EDGAR
- May 4, 2022SC TO-I/A EDGAR
- Apr 22, 2022CORRESP EDGAR
- Apr 22, 2022SC TO-I/A EDGAR
- Apr 18, 2022UPLOAD EDGAR
- Apr 12, 2022UPLOAD EDGAR
- Apr 1, 2022SC TO-I EDGAR
- Mar 23, 2022CORRESP EDGAR
- Feb 22, 202210-Q EDGAR
- Feb 15, 2022NT 10-Q EDGAR
- Feb 9, 20228-K EDGAR
- Feb 2, 2022UPLOAD EDGAR
- Nov 18, 202110-Q EDGAR
- Nov 16, 2021NT 10-Q EDGAR
- Nov 10, 20218-K EDGAR
- Oct 12, 20218-K EDGAR
The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Kyto Technology & Life Science, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARKyto Technology & Life Science, Inc.1
- CIK0001164888
- Employer ID (EIN)65-10865381
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inDelaware1
- Fiscal year endsMarch 311
- Industry code (SIC)2834 Pharmaceutical Preparations1
- Business address13050 Paloma Road, Los Altos Hills, CA 940221
- Phone650-204-78961
- Shares outstanding13,287,621 as of Feb 18, 20226
- Public float$973.9K as of Sep 30, 20202
- On EDGAR sinceJan 18, 20021
- Filings212 in all: 10-Q (42), 8-K (30), 4 (18), UPLOAD (15), 10QSB (14), 10-K (13), CORRESP (11), NT 10-Q (8)1
All 34 form types
10-K/A (6), 10-Q/A (6), SC 13D (6), SC TO-I/A (6), 10KSB (5), 3 (5), 10KSB/A (2), 4/A (2), 5 (2), NT 10-K (2), PRER14A (2), SB-2/A (2), SC TO-I (2), 10SB12G (1), 15-12G (1), 425 (1), D (1), DEF 14A (1), NTN 10Q (1), PRE 14A (1), RW (1), S-8 (1), S-8 POS (1), SB-2 (1), SC 13G (1), SC 13G/A (1)
- Latest filingsAnnual report (10-K) Aug 10, 2021
Quarterly report (10-Q) Feb 22, 2022
Proxy statement (DEF 14A) Jun 17, 2019
Latest 8-K (8-K) May 9, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARGeorges Benarroch, President
- 8SEC EDGARGeorges Benarroch, Officer
- 9SEC EDGARGeorges Benarroch, Board member
- 10SEC EDGAROther events
- 11SEC EDGARUnregistered sale of shares
- 12SEC EDGARExecutive or director change
- 13SEC EDGARBylaws or fiscal year changed